Position in ACET
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$810,535
+$171,676 QoQ
Shares Held
93,812
0.0% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#16
of 56 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. ACET ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in ACET
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $810,535 | 93,812 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $638,859 | 93,812 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $789,897 | 93,812 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $329,400 | 540,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $453,000 | 600,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $577,200 | 600,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $864,000 | 600,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $726,000 | 600,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,410,000 | 600,000 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $1,091,963 | 797,054 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,936,841 | 797,054 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,591,031 | 797,054 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,646,092 | 631,554 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,306,592 | 935,766 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,662,183 | 935,766 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,295,963 | 715,872 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,823,178 | 733,172 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,950,043 | 376,281 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,871,931 | 376,281 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,036,807 | 385,077 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,089,956 | 77,577 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $803,490 | 67,577 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||